- 월간 총 방문수
- 아직 없음
- 아직 방문 데이터 없음
- 공개 매출
- 비공개
- 보유 제품의 공개 수익 없음
제품
| 제품 | 월간 방문 · 10월 | 작업 |
|---|---|---|
| EquitAIWall Street, Translated for You. | <5K |
타임라인
11월 20일 · 3일 전
EquitAI reports Williams-Sonoma Q3 earnings beat추천 및 백링크
EquitAI's post says comparable brand revenue rose 5.1% and GAAP diluted EPS increased 21.4% to $2.38. It attributes the results to tariff refunds and margin expansion, and displays EquitAI DNA scores.
EquitAI reports PGE's $350M term-loan expansion추천 및 백링크
The post says PGE expanded its term loan by $350M to $700M and drew $200M immediately. It flags rising leverage and floating-rate exposure ahead of the 2028 maturity, and displays EquitAI DNA scores.
11월 19일 · 4일 전
EquitAI reports GEOS FY2026 results and new credit facility추천 및 백링크
EquitAI's post says GEOS reported FY2026 revenue of $80.7M and a net loss of $44.3M. It also says the company entered a new $25M revolving credit facility that replaced prior debt.
EquitAI reports Q3 revenue growth and raises FY27 outlook제품 활동
The post says revenue grew 51% year over year to $1.5B and that the FY27 revenue outlook was raised to $5.21B.
EquitAI reports on $SEGG equity line termination추천 및 백링크
EquitAI's post identifies an SEC 8-K alert for $SEGG and says the company terminated its $300M equity line agreement after drawing $5.9M. The post also displays EquitAI DNA quality and strength scores.
EquitAI reports AIFA's $8 million acquisition of Little Vault추천 및 백링크
EquitAI's post identifies an SEC 8-K alert and says AIFA agreed to acquire Little Vault Inc. for $8 million in newly issued common stock from its incoming CEO. The post also shows EquitAI DNA scores.
EquitAI covers Marker Therapeutics’ $16.2M CPRIT grant추천 및 백링크
EquitAI’s post identifies a Marker Therapeutics SEC 8-K alert and says the company secured a $16.2M CPRIT grant to fund its Phase 2 APOLLO trial for MT-601. The post also displays EquitAI DNA strength and growth scores.
EquitAI covers Textron's $1.2B industrial divestiture추천 및 백링크
EquitAI's post says Textron is shedding its Industrial segment for $1.2B cash and plans to deploy net proceeds into buybacks. It also displays an EquitAI DNA strength score of 9/10 and dividend score of 4/10.
EquitAI reports Target's Q3 EPS and tariff refund benefit추천 및 백링크
EquitAI says Target posted Q3 EPS of $2.65, including a $0.50 tariff refund benefit, and revised its full-year guidance upward. The post also says comparable sales grew 5.6 percent and displays an EquitAI DNA growth score.
EquitAI reports PTFI pricing $750M of senior notes추천 및 백링크
The post says PTFI priced $750M of 6.90% senior notes due 2033 to refinance existing obligations. It also characterizes the transaction as locking in higher structural leverage.
11월 10일 · 13일 전
EquitAI 최초 출시신제품
주요 질문과 근거
- Ali C은(는) 어떤 제품들을 만들었나요?
- EarlyLore에는 Ali C의 독립 소프트웨어 제품 1개(현재 운영 중 1개)가 등록되어 있으며, EquitAI 등이 대표적입니다.
관련 인디 메이커 리서치 가이드